This stock will go nowhere until revenue is assured
While I would much rather see $ booked and disclosed (than not) I disagree this will go nowhere until then. How often is it the expectation of revenue that drives a sp on the ASX? Very often. MDR has been listed for not even 6 months and it's in the marketing and "distributions" phase. If one is chasing stocks with fast growing revenue, the $100-200M mc space is more the place to be, in general.
Ann: Novartis Pharmaceuticals Australia to use MedAdvisor-MDR.AX, page-8
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
